Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
20.98
-0.16 (-0.76%)
Nov 16, 2026, 4:00 PM EST - Market closed
Tectonic Therapeutic Market Cap
Tectonic Therapeutic has a market cap or net worth of $410.15 million as of November 16, 2026. It is the 15,689th most valuable company in the world and the 2,848th biggest in the United States. Its market cap has increased by 18.20% in one year.
Market Cap
410.15M
Enterprise Value
179.40M
1-Year Change
18.20%
Global Rank
Country Rank
#2,848 United States
Category
ChartMarket Cap Chart
Since June 21, 2024, Tectonic Therapeutic's market cap has increased from $250.63M to $410.15M, an increase of 63.65%. That is a compound annual growth rate of 22.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 410.15M | 5.05% |
| Dec 31, 2025 | 390.42M | -42.68% |
| Dec 31, 2024 | 681.13M | 171.77% |
| Jun 21, 2024 | 250.63M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CytomX Therapeutics | 444.73M |
| Assembly Biosciences | 432.48M |
| Prothena Corporation | 419.01M |
| SL Science Holding | 414.58M |
| Fennec Pharmaceuticals | 410.25M |
| MapLight Therapeutics | 402.92M |
| Puma Biotechnology | 401.70M |
| ARS Pharmaceuticals | 391.06M |